Key Centrifugal Blood Pumps Market Players:
- Abbott Laboratories
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Braile Biomedica
- Getinge AB
- Hugo Sachs Elektronik
- LivaNova PLC
- Medtronic plc
- Senko Medical Instrument Mfg. Co., Ltd.
- Spectrum Medical
The centrifugal blood pumps market is diversified by company type, ranging from well-established companies in the medical device business to emerging startups, all of which are looking to innovate and improve cardiac support technologies. Companies are leveraging their extensive research capabilities and distribution networks to their advantage in offering more extensive product offerings. In addition, companies are directing efforts toward the miniaturization of pumps and easier integration into clinical workflows.
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
In the year 2026, the industry size of centrifugal blood pumps is evaluated at USD 105.21 million.
Centrifugal Blood Pumps Market size was valued at USD 100.51 million in 2025 and is set to exceed USD 166.87 million by 2035, registering over 5.2% CAGR during the forecast period i.e., between 2026-2035.
North America leads the Centrifugal Blood Pumps market with a 43.1% share, driven by technological advancement and prevalence of cardiovascular diseases, enhancing treatment outcomes through 2026–2035.
Key players in the market include Abbott Laboratories, Braile Biomedica, Getinge AB, Hugo Sachs Elektronik, LivaNova PLC, Medtronic plc, Senko Medical Instrument Mfg. Co., Ltd., Spectrum Medical, and more.
